Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 425
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00003916 | Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma | ||
| NCT00006121 | Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy | ||
| NCT00002878 | Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma | ||
| NCT00003888 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer | ||
| NCT00002903 | Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer | ||
| NCT01788982 | Nintedanib(BIBF1120) in Thyroid Cancer | ||
| NCT00086879 | Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme | ||
| NCT04127110 | Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients | ||
| NCT05974774 | Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors | ||
| NCT01524926 | CREATE: Cross-tumoral Phase 2 With Crizotinib | ||
| NCT00002719 | Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia | ||
| NCT05904119 | Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study | ||
| NCT00052312 | Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer | ||
| NCT03859453 | Follow-up in Early and Locally Advanced Breast Cancer Patients | ||
| NCT02362594 | Study of Pembrolizumab (MK-3475) Versus Placebo After Complete Resection of High-Risk Stage III Melanoma (MK-3475-054/1325-MG/KEYNOTE-054) | ||
| NCT00003681 | Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome | ||
| NCT02866370 | Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium | ||
| NCT00002539 | Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma | ||
| NCT00433563 | Concurrent Once Daily Versus Twice Daily Radiotherapy for Limited Stage Small Cell Lung Cancer | ||
| NCT00039338 | Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer | ||
| NCT01290939 | Bevacizumab and Lomustine for Recurrent GBM | ||
| NCT00053807 | Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer | ||
| NCT00016211 | Radiation Therapy to Prevent Brain Metastases in Patients With Previously Treated Extensive-Stage Small Cell Lung Cancer | ||
| NCT00626990 | Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH) | ||
| NCT00006352 | Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer | ||
| NCT03134118 | Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM) | ||
| NCT00849082 | Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer | ||
| NCT00410462 | Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma | ||
| NCT02234050 | Trabectedin for Recurrent Grade II/III Meningioma | ||
| NCT02273271 | Evaluation of FLT-PET and DWI-MRI in Patients With NSCLC Treated With a Platinum-based Doublet as Preoperative Chemo | ||
| NCT00689221 | Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status | ||
| NCT03818503 | E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe | ||
| NCT03676218 | Assessing Patient-reported & Patient-related Outcomes in Randomized Cancer Trials for Older Adults | ||
| NCT01101425 | Male Breast Cancer: Understanding the Biology for Improved Patient Care | ||
| NCT00389688 | Pemetrexed Disodium and Cisplatin Before or After Surgery in Treating Patients With Stage IB or Stage II Non-Small Cell Lung Cancer That Can be Removed by Surgery | ||
| NCT00002651 | SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer | ||
| NCT03235245 | Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib | ||
| NCT06809322 | Vorasidenib Maintenance for IDH Mutant Astrocytoma | ||
| NCT01476462 | Second Malignant Neoplasms After Childhood ALL Therapy | ||
| NCT03357224 | PARCT: Trial of Atezolizumab in Relapsed/Refractory Cutaneous T Cell Lymphoma (CTCL) | ||
| NCT00049595 | Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma | ||
| NCT01942603 | Minimal SN Tumor Burden | ||
| NCT04685616 | Brentuximab Vedotin in Early Stage Hodgkin Lymphoma | ||
| NCT00470236 | Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast | ||
| NCT00623064 | Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer | ||
| NCT00003589 | Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer | ||
| NCT00004254 | Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed | ||
| NCT00074074 | Infliximab in Treating Patients With Myelodysplastic Syndrome | ||
| NCT06347185 | Simultaneous Care in Recurrent and/or Metastatic Head and Neck Cancer: the SupCare Study | ||
| NCT01969578 | Androgen Deprivation Therapy in Advanced Salivary Gland Cancer |
